| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.008 | 1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |